Clinical Trials Directory

Trials / Completed

CompletedNCT06993467

Oxygen Delivery During Cardiopulmonary Bypass And Inflammatory Reaction After Cardiac Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
908 (actual)
Sponsor
Azienda Ospedaliero, Universitaria Ospedali Riuniti · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Cardiac surgery, especially when involving cardiopulmonary bypass (CPB), has long been associated with a systemic inflammatory response that can lead to a range of complications, from mild symptoms to severe organ dysfunction, and mortality. The exact mechanisms behind this response remain a topic of extensive research, but it's clear that the body's reaction to the extracorporeal circulation, combined with surgical trauma, plays a significant role. Factors such as genomics, age, specific preoperative conditions, and the duration of operations have been associated with significant clinical responses. A pivotal insight into this response comes from recent genome-wide transcriptional analyses. Perioperative ischemia and ischemia-reperfusion injury (IRI) have been suggested as hub-nodes in a hierarchic structure evaluating the response to cardiac surgery. This suggests that IRI isn't just a side effect of the surgery but might be a central player in the body's inflammatory response. The role of perioperative ischemia and its potential as a significant contributor to the postoperative inflammatory response cannot be understated. This study aims to delve deeper into the role of oxygen delivery and its implications in the systemic inflammatory response post- cardiac surgery.

Conditions

Timeline

Start date
2023-10-30
Primary completion
2024-12-31
Completion
2025-01-31
First posted
2025-05-28
Last updated
2025-05-28

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT06993467. Inclusion in this directory is not an endorsement.